{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:46:01Z","timestamp":1773683161917,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T00:00:00Z","timestamp":1339718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00520-012-1511-y","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T10:05:23Z","timestamp":1340013923000},"page":"2621-2626","source":"Crossref","is-referenced-by-count":22,"title":["Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma"],"prefix":"10.1007","volume":"20","author":[{"given":"Claudio","family":"Cartoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregorio Antonio","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Efficace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Grammatico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tendas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Scaramucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cupelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna Maria","family":"D\u2019Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Truini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Niscola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,15]]},"reference":[{"issue":"9","key":"1511_CR1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00277-007-0296-4","volume":"86","author":"P Niscola","year":"2007","unstructured":"Niscola P, Cartoni C, Romani C, Brunetti GA, D'Elia GM, Cupelli L, Tendas A, de Fabritiis P, Mandelli F, Fo\u00e0 R (2007) Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey. Ann Hematol 86(9):671\u2013676","journal-title":"Ann Hematol"},{"issue":"4","key":"1511_CR2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.thj.6200530","volume":"5","author":"P Niscola","year":"2004","unstructured":"Niscola P, Arcuri E, Giovannini M, Scaramucci L, Romani C, Palombi F, Trap\u00e8 G, Morabito F (2004) Pain syndromes in haematological malignancies: an overview. Hematol J 5(4):293\u2013303","journal-title":"Hematol J"},{"issue":"1","key":"1511_CR3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.leukres.2007.03.024","volume":"32","author":"P Niscola","year":"2008","unstructured":"Niscola P, Romani C, Cartoni C, Cupelli L, Piccioni D, Dentamaro T, Tendas A, Giovannini M, Scaramucci L, Tolu B, Perrotti AP, de Fabritiis P (2008) Epidemiology of pain in hospital haematological setting: an Italian survey. Leuk Res 32(1):197\u2013198","journal-title":"Leuk Res"},{"key":"1511_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(01)01302-4","volume":"429","author":"TS Jensen","year":"2001","unstructured":"Jensen TS, Gottrup H, Sindrup SH, Bach FW (2001) The clinical picture of neuropathic pain. Eur J Pharamacol 429:1\u201311","journal-title":"Eur J Pharamacol"},{"issue":"4","key":"1511_CR5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1529-8027.2008.00193.x","volume":"13","author":"V Chaudhry","year":"2008","unstructured":"Chaudhry V, Cornblath DR, Polydefkis M, Ferguson A, Borrello I (2008) Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy. J Peripher Nerv Syst 13(4):275\u2013282","journal-title":"J Peripher Nerv Syst"},{"issue":"5","key":"1511_CR6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","volume":"112","author":"AA Argyriou","year":"2008","unstructured":"Argyriou AA, Iconomou G, Kalofonos HP (2008) Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood 112(5):1593\u20131599","journal-title":"Blood"},{"issue":"19","key":"1511_CR7","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2005.04.7779","volume":"24","author":"PG Richardson","year":"2006","unstructured":"Richardson PG, Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J, Singhal S, Siegel DS, Irwin D, Schuster M, Srkalovic G, Alexanian R, Rajkumar SV, Limentani S, Alsina M, Orlowski RZ, Najarian K, Esseltine D, Anderson KC, Amato AA (2006) Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. J Clin Oncol 24(19):3113\u20133120","journal-title":"J Clin Oncol"},{"key":"1511_CR8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0801479","volume":"359","author":"JF San Miguel","year":"2008","unstructured":"San Miguel JF, Schlag R, Khuageva NK (2008) Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med 359:906\u2013917","journal-title":"N Engl J Med"},{"issue":"6","key":"1511_CR9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2141.2009.07775.x","volume":"146","author":"J Gerecitano","year":"2009","unstructured":"Gerecitano J, Portlock C, Moskowitz C, Hamlin P, Straus D, Zelenetz AD, Zhang Z, Dumitrescu O, Sarasohn D, Lin D, Pappanicholaou J, Cortelli BM, Neylon E, Hamelers R, Wright J, O'Connor OA (2009) Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma. Br J Haematol 146(6):652\u2013655","journal-title":"Br J Haematol"},{"issue":"1","key":"1511_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","volume":"204","author":"G Cavaletti","year":"2007","unstructured":"Cavaletti G, Gilardini A, Canta A, Rigamonti L, Rodriguez-Menendez V, Ceresa C, Marmiroli P, Bossi M, Oggioni N, D'Incalci M, De Coster R (2007) Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat. Exp Neurol 204(1):317\u2013325","journal-title":"Exp Neurol"},{"issue":"4","key":"1511_CR11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpain.2006.09.014","volume":"8","author":"JP Cata","year":"2007","unstructured":"Cata JP, Weng HR, Burton AW, Villareal H, Giralt S, Dougherty PM (2007) Quantitative sensory findings in patients with bortezomib-induced pain. J Pain 8(4):296\u2013306","journal-title":"J Pain"},{"issue":"18","key":"1511_CR12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","volume":"29;70","author":"RD Treede","year":"2008","unstructured":"Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 29;70(18):1630\u20131635","journal-title":"Neurology"},{"issue":"10","key":"1511_CR13","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3324\/haematol.11752","volume":"92","author":"G Cavaletti","year":"2007","unstructured":"Cavaletti G, Nobile-Orazio E (2007) Bortezomib-induced peripheral neurotoxicity: still far from a painless gain. Haematologica 92(10):1308\u20131310","journal-title":"Haematologica"},{"issue":"6","key":"1511_CR14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2141.2009.07803.x","volume":"146","author":"S Jagannath","year":"2009","unstructured":"Jagannath S, Durie BG, Wolf JL, Camacho ES, Irwin D, Lutzky J, McKinley M, Potts P, Gabayan AE, Mazumder A, Crowley J, Vescio R (2009) Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma. Br J Haematol 146(6):619\u2013626","journal-title":"Br J Haematol"},{"issue":"6","key":"1511_CR15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2141.2008.07573.x","volume":"144","author":"PG Richardson","year":"2009","unstructured":"Richardson PG, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Blad\u00e9 J, Boccadoro M, Cavenagh JD, Boral AL, Esseltine DL, Wen PY, Amato AA, Anderson KC, San Miguel J (2009) Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline. Br J Haematol 144(6):895\u2013903","journal-title":"Br J Haematol"},{"issue":"11","key":"1511_CR16","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","volume":"13","author":"N Attal","year":"2006","unstructured":"Attal N, Cruccu G, Haanp\u00e4\u00e4 M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P, EFNS Task Force (2006) EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13(11):1153\u20131169","journal-title":"Eur J Neurol"},{"key":"1511_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","volume":"132","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, O\u2019Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice ASC, Stacey BR, Treede RD, Turk DC, Wallace MS (2007) Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 132:237\u2013251","journal-title":"Pain"},{"issue":"5","key":"1511_CR18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/WCO.0b013e3283311e13","volume":"22","author":"TS Jensen","year":"2009","unstructured":"Jensen TS, Madsen CS, Finnerup NB (2009) Pharmacology and treatment of neuropathic pains. Curr Opin Neurol 22(5):467\u2013474","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"1511_CR19","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","volume":"50","author":"CP Watson","year":"1998","unstructured":"Watson CP, Babul N (1998) Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50(6):1837\u20131841","journal-title":"Neurology"},{"issue":"1\u20132","key":"1511_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","volume":"105","author":"CP Watson","year":"2003","unstructured":"Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J (2003) Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105(1\u20132):71\u201378","journal-title":"Pain."},{"issue":"2","key":"1511_CR21","first-page":"45","volume":"14","author":"P Niscola","year":"2007","unstructured":"Niscola P, Perrotti AP, del Poeta G, Romani C, Palombi M, Piccioni D, Scaramucci L, Tolu B, Tendas A, Cupelli L, Abruzzese E, D'Elia GM, Brunetti GA, Maurillo L, Giovannini M, Cartoni C, de Fabritiis P (2007) Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures. Herpes 14(2):45\u201347","journal-title":"Herpes"},{"issue":"3","key":"1511_CR22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000186502","volume":"61","author":"A Gatti","year":"2009","unstructured":"Gatti A, Sabato AF, Occhioni R, Colini Baldeschi G, Reale C (2009) Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study. Eur Neurol 61(3):129\u2013137","journal-title":"Eur Neurol"},{"key":"1511_CR23","unstructured":"No authors listed. National Cancer Institute: Common Terminology Criteria for Adverse Events v3.0 (CTCAE) Available from http:\/\/ctep.cancer.gov\/forms\/CTCv2"},{"key":"1511_CR24","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2174\/092986708786848622","volume":"15","author":"A Gilardini","year":"2008","unstructured":"Gilardini A, Marmiroli P, Cavaletti G (2008) Proteasome inhibition: a promising strategy for treating cancer, but what about neurotoxicity? Curr Med Chem 15:3025\u20133035","journal-title":"Curr Med Chem"},{"issue":"4","key":"1511_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/J354v20n04_06","volume":"20","author":"M Bercovitch","year":"2006","unstructured":"Bercovitch M, Adunsky A (2006) High dose controlled-release oxycodone in hospice care. J Pain Palliat Care Pharmacother 20(4):33\u201339","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"8","key":"1511_CR26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00277-005-0062-4","volume":"85","author":"P Niscola","year":"2006","unstructured":"Niscola P, Scaramucci L, Romani C, Giovannini M, Maurillo L, del Poeta G, Cartoni C, Arcuri E, Amadori S, De Fabritiis P (2006) Opioids in pain management of blood-related malignancies. Ann Hematol 85(8):489\u2013501","journal-title":"Ann Hematol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1511-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-012-1511-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1511-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:04:18Z","timestamp":1559081058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1511-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,15]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1511-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,15]]}}}